pubmed-article:12239500 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0027358 | lld:lifeskim |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0232478 | lld:lifeskim |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0722364 | lld:lifeskim |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
pubmed-article:12239500 | lifeskim:mentions | umls-concept:C0522501 | lld:lifeskim |
pubmed-article:12239500 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12239500 | pubmed:dateCreated | 2002-9-19 | lld:pubmed |
pubmed-article:12239500 | pubmed:abstractText | OxyContin (oxycodone hydrochloride controlled release) is a long-acting preparation of oxycodone that is used as an opioid analgesic to treat chronic pain conditions. We report a patient who ingested a massive quantity of OxyContin and had altered mental status, noncardiogenic pulmonary edema, and hypoventilation that proved refractory to naloxone administration. She required mechanical ventilation for 3 days before recovering completely. The severity and length of poisoning was likely related both to the quantity and formulation of the oxycodone ingested. | lld:pubmed |
pubmed-article:12239500 | pubmed:language | eng | lld:pubmed |
pubmed-article:12239500 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239500 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12239500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239500 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12239500 | pubmed:month | Oct | lld:pubmed |
pubmed-article:12239500 | pubmed:issn | 0196-0644 | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:WilliamsSaral... | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:ClarkRichard... | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:LyBinh TBT | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:SchneirAaron... | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:VadeboncoeurT... | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:OffermanSteve... | lld:pubmed |
pubmed-article:12239500 | pubmed:author | pubmed-author:BarryJames... | lld:pubmed |
pubmed-article:12239500 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12239500 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:12239500 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12239500 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12239500 | pubmed:pagination | 425-8 | lld:pubmed |
pubmed-article:12239500 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:meshHeading | pubmed-meshheading:12239500... | lld:pubmed |
pubmed-article:12239500 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12239500 | pubmed:articleTitle | Massive OxyContin ingestion refractory to naloxone therapy. | lld:pubmed |
pubmed-article:12239500 | pubmed:affiliation | Division of Medical Toxicology, Department of Emergency Medicine, University of California San Diego Medical Center, 92103-8925, USA. aschneir@ucsd.edu | lld:pubmed |
pubmed-article:12239500 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12239500 | pubmed:publicationType | Case Reports | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12239500 | lld:pubmed |